Weight Loss Drug Recalled Due to Potential Serious Side Effects
A popular weight loss medication has been recalled by its manufacturer due to concerns over potential serious side effects. The recall affects thousands of patients who have been taking the drug, and health experts are urging those affected to stop taking the medication immediately and consult with their doctor.
What is the recalled medication?
The recalled medication is a prescription-only weight loss pill called “Lydian” (generic name: orlistat). It was approved by the U.S. Food and Drug Administration (FDA) in 2017 and was marketed by the pharmaceutical company, Lydian Pharmaceuticals. The medication was designed to help obese patients lose weight by reducing the amount of fat that is digested and absorbed by the body.
Reason for recall
The recall was issued due to reports of serious side effects, including:
- Increased risk of liver damage
- Severe allergic reactions
- Neurological problems, including dizziness, vertigo, and confusion
- Increased risk of pancreatitis, a serious and potentially life-threatening condition
The FDA has received hundreds of reports of adverse reactions associated with Lydian, including several cases of serious liver injury and pancreatitis. As a result, the agency has ordered the recall of all batches of Lydian that are still in circulation.
How affected patients can proceed
Patients who are currently taking Lydian are urged to stop taking the medication immediately and consult with their doctor or healthcare provider. Patients who are experiencing any symptoms or side effects should seek medical attention right away.
In addition, patients who are affected by the recall may be eligible for a replacement or refund. Lydian Pharmaceuticals has established a patient assistance program to help affected patients access alternative treatments.
What are the alternatives?
In the meantime, patients who are affected by the recall may be able to switch to alternative weight loss medications or therapies, such as:
- Lifestyle changes, such as diet and exercise
- Other prescription medications, such as phentermine-topiramate (Qsymia) or lorcaserin (Belviq)
- Over-the-counter weight loss supplements, such as orlistat (Alli)
- Bariatric surgery
Patients who are interested in exploring alternative treatment options should consult with their doctor or healthcare provider to determine the best course of treatment.
Conclusion
The recall of Lydian is a major concern for patients who have been taking the medication, and it highlights the importance of monitoring the safety and effectiveness of all medications. The FDA and Lydian Pharmaceuticals urge patients to take immediate action and seek medical attention if they are experiencing any symptoms or side effects. By working together, patients and healthcare providers can ensure the safest and most effective treatment options are available.
